<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02977793</url>
  </required_header>
  <id_info>
    <org_study_id>TOMEY-EM4000-US-001</org_study_id>
    <nct_id>NCT02977793</nct_id>
  </id_info>
  <brief_title>Comparative Study of the TOMEY Specular Microscope EM-4000 and the Konan CellChek XL</brief_title>
  <official_title>Comparative Study of the TOMEY Specular Microscope EM-4000 and the Konan CellChek XL for the Measurements of Endothelial Cell Density, Coefficient of Variation of Endothelial Cell Area, % Hexagonality, Central Corneal Thickness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tomey Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tomey Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Tomey EM-4000 Specular Microscope is designed to observe and analyze corneal endothelium.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Tomey EM-4000 Specular Microscope is designed to observe and analyze corneal endothelium&#xD;
      by capturing an image of corneal endothelium tissues. without making contact, analyzing the&#xD;
      captured image, and calculating data such as cell density.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial cell density measurements</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Coefficient of variation of endothelial cell area</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>% Hexagonality</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Central Corneal Thickness</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">81</enrollment>
  <condition>Corneal and Endothelial Cell Measurements</condition>
  <arm_group>
    <arm_group_label>Non-pathologic young adults</arm_group_label>
    <description>18-28 years old</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-pathologic adults</arm_group_label>
    <description>29-80 years old</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pathologic adults</arm_group_label>
    <description>29-80 years old</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tomey EM-4000 Specular Microscope</intervention_name>
    <arm_group_label>Non-pathologic adults</arm_group_label>
    <arm_group_label>Non-pathologic young adults</arm_group_label>
    <arm_group_label>Pathologic adults</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Konan CellChek XL Specular Microscope</intervention_name>
    <arm_group_label>Non-pathologic adults</arm_group_label>
    <arm_group_label>Non-pathologic young adults</arm_group_label>
    <arm_group_label>Pathologic adults</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects recruited can be male or female, of any race or ethnicity, ages 18-80 years of age&#xD;
        at Visit 1. All subjects enrolled must meet all the inclusion criteria and none of the&#xD;
        exclusion criteria.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria-Non-pathologic young adults (18-28 years old) and non-pathologic adults&#xD;
        (29-80 years old)&#xD;
&#xD;
          1. Male or female subjects from 18 to 80 years old who have full legal capacity to&#xD;
             volunteer on the date the informed consent is signed;&#xD;
&#xD;
          2. Subjects who can follow the instructions by the clinical staff at the clinical site,&#xD;
             and can attend examinations on the scheduled examination date;&#xD;
&#xD;
          3. Subjects who agree to participate in the study.&#xD;
&#xD;
        Inclusion Criteria -Pathologic adults (29-80 years old):&#xD;
&#xD;
          1. Male and female subjects from 29 to 80 years old who have full legal capacity to&#xD;
             volunteer on the date the informed consent is signed;&#xD;
&#xD;
          2. Subjects who can follow the instructions by the clinical staff at the clinical site,&#xD;
             and can attend examinations on the scheduled examination date;&#xD;
&#xD;
          3. Subjects who agree to participate in the study;&#xD;
&#xD;
          4. At least one eye with any of the following conditions:&#xD;
&#xD;
               1. History of post-op surgical trauma including pseudophakic or aphakic bullous&#xD;
                  keratopathy&#xD;
&#xD;
               2. History of corneal transplant&#xD;
&#xD;
               3. Physical injury or trauma to the cornea&#xD;
&#xD;
               4. Fuch's dystrophy, Guttata or other corneal endothelial dystrophies&#xD;
&#xD;
               5. Keratoconus&#xD;
&#xD;
               6. Long-term polymethyl methacrylate (PMMA) contact lens use (greater than 3 years).&#xD;
&#xD;
        Exclusion Criteria - Non-pathologic young adults (18-28 years old) and non-pathologic&#xD;
        adults (29-80 years old)&#xD;
&#xD;
          1. History of post-op surgical trauma including bullous keratopathy;&#xD;
&#xD;
          2. History of corneal transplant;&#xD;
&#xD;
          3. Evidence of physical injury or trauma to the cornea;&#xD;
&#xD;
          4. Fuch's dystrophy, Guttata or other corneal endothelial dystrophies;&#xD;
&#xD;
          5. Keratoconus;&#xD;
&#xD;
          6. Long-term PMMA contact lens use (greater than 3 years);&#xD;
&#xD;
          7. History of cataract, refractive or ocular surgical procedures that render the cornea&#xD;
             opaque or otherwise impact its ability to be imaged using the investigational device;&#xD;
&#xD;
          8. Fixation problems which may prevent obtaining good Tomey EM-4000 and Konan CellChek XL&#xD;
             images in either eye.&#xD;
&#xD;
        Exclusion Criteria - Pathologic adults (29-80 years old)&#xD;
&#xD;
          1. History of cataract, refractive or ocular surgical procedures that render the cornea&#xD;
             opaque or otherwise impact its ability to be imaged using the investigational device;&#xD;
&#xD;
          2. Fixation problems which may prevent obtaining at least poor quality Tomey EM-4000 and&#xD;
             Konan CellChek XL images in either eye.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2016</verification_date>
  <study_first_submitted>November 28, 2016</study_first_submitted>
  <study_first_submitted_qc>November 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2016</study_first_posted>
  <last_update_submitted>November 28, 2016</last_update_submitted>
  <last_update_submitted_qc>November 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

